CDI(CODX) - 2023 Q4 - Annual Results

Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results Full Year 2023 Business Highlights: "We are pleased to have made great progress towards our strategic goals in the fourth quarter, highlighted by an Emergency Use Authorization submission to the FDA for our Co-Dx PCR Pro™ instrument, mobile app, and COVID-19 test," said Dwight Egan, CoDiagnostics' Chief Executive Officer. "We believe that our EUA submission will serve as a steppingstone in our effort to decentralize PCR diagnostics and to expand ...